Viewing nowCombinationCrestive Tablet 10/2.5 mg (Ezetimibe, Rosuvastatin)
Ezetimibe 10mg · Rosuvastatin Calcium 2.6mg
Tablet · Prescription medication · Combination
Korea Hutex Pharmaceutical Co., Ltd.

MFDS item code 202501477 · Approved 2025.06.17 · Insurance code 649106140
Improvement of primary hypercholesterolemia and mixed dyslipidemia
This medication is used in patients with primary hypercholesterolemia and mixed dyslipidemia, helping to lower total cholesterol, LDL cholesterol, Apo B protein, triglycerides, and non-HDL cholesterol levels. Conversely, it increases HDL cholesterol, thus improving blood lipid balance. It is primarily used as an adjunct to dietary treatment, contributing to effectively managing patients' blood lipid levels. This medication helps to reduce the risk of cardiovascular diseases through cholesterol regulation. Therefore, it is used for the management of hypercholesterolemia and dyslipidemia.
This medicine is administered once daily, regardless of food. Patients must continue a standard cholesterol-lowering diet before and during treatment with this medicine. The dose of this medicine should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment target, and response. Primary hypercholesterolemia The dose range of this medicine is 10/2.5mg∼10/20mg once daily. The recommended initial dose is 10/2.5mg or 10/5mg once daily. The dose may be adjusted for patients who require a greater reduction in LDL cholesterol. After starting treatment with this medicine or adjusting the dose, check blood lipid levels at intervals of at least 4 weeks and adjust the dose accordingly; the dose may be increased to a maximum of 10/20mg once daily. For patients taking ezetimibe and rosuvastatin concomitantly, they may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience.
This medication can rarely cause rhabdomyolysis, which can lead to serious muscle issues, so treatment should be temporarily or completely discontinued if acute myopathy symptoms appear or if there is a risk of severe kidney problems. This medication should not be used in patients who are allergic to its main component or ingredients, or in those with liver disease, myopathy, severe renal failure, or in women who are pregnant or breastfeeding. Patients at higher risk of myopathy, such as those with decreased kidney function, hypothyroidism, or elderly patients, should be particularly cautious when using this medication. If symptoms such as myalgia, muscle cramps, or muscle weakness occur during treatment, the patient should immediately inform their healthcare provider, and blood tests may be needed to check for muscle damage. Since it can affect liver function, liver function tests should be performed before starting treatment. If symptoms of liver damage occur during treatment, immediate testing is required, and in severe cases, discontinuation of the medication is necessary. This medication should be used cautiously in patients with a history of excessive alcohol use or liver disease. Blood sugar levels may rise while taking this medication, so patients at risk for diabetes should regularly monitor their blood sugar levels. There may be interactions when taken with other medications, so patients should inform their doctor or pharmacist of any other medications they are taking. Women who are pregnant or may become pregnant should not take this medication, and if pregnancy is confirmed during treatment, it should be discontinued immediately. Breastfeeding women should also avoid this medication for safety. Safety in pediatric patients has not been established, so it is not recommended, and caution is needed for elderly patients due to the risk of myopathy. In the case of overdose, there is no specific antidote, and appropriate treatment and supportive care should be received based on symptoms, while monitoring liver function and muscle condition should be essential. This medication should be stored out of the reach of children, and transferring it to other containers should be avoided.
Acute kidney failure due to myoglobinuria, rhabdomyolysis, myalgia, nasopharyngitis, migraine, sensory impairment, aphthous ulcer, chronic gastritis, gout, increased C-reactive protein, arthralgia, headache, elevated ALT, elevated AST, edema, increased serum bilirubin, acnedermatitis, pruritus, dizziness, upper respiratory infection, drowsiness, neurodegenerative disorders, orthostatic dizziness, myopathy, myositis, weakness, angioedema, diabetes, thrombocytopenia, jaundice, hepatitis, toxic hepatitis, Stevens-Johnson syndrome, eosinophilia accompanied by systemic symptoms drug reaction syndrome, psoriasiform drug eruption, lupus-like syndrome, muscle rupture, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, memory decline, forgetfulness, amnesia, memory impairment, confusion, urticaria, itching, rash, limb pain, arthralgia, constipation, nausea, abdominal pain, diarrhea, loss of appetite, abdominal distension, abnormal liver function tests, syncope, widespread pain, muscle cramps, erectile dysfunction, chest pain, chest discomfort, generalized edema, diabetic neuropathy, tremors, upper abdominal pain, vomiting, gastritis, dry mouth, epigastric discomfort, belching, gastrointestinal disorders, gastroesophageal reflux disease, tongue disorders, palpitations, congestive heart failure, myocardial ischemia, flushing, cough, phlegm, runny nose, anemia, splenomegaly, conjunctival injection, renal failure, increased serum creatinine, elevated blood pressure, increased serum urea, increased CPK, abnormal liver function
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it must be stored in a tightly sealed container. The storage temperature should be kept at room temperature between 1 degree Celsius and 30 degrees Celsius. Storing it this way can help maintain the effectiveness of the medication.
White oval film-coated tablet
100 tablets/bottle, 30 tablets/bottle, 30 tablets/box [(10 tablets/PTP x 3, Alu-Alu)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEzetimibe 10mg · Rosuvastatin Calcium 2.6mg
Tablet · Prescription medication · Combination
Korea Hutex Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 5.2mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 20.8mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Myeongmun Pharmaceutical Co., Ltd.
CombinationEzetimibe 10mg · Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication · Combination
Kyungdong Pharmaceutical Co., Ltd.
CombinationEzetimibe 10mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Kyungdong Pharm. Co., Ltd.
CombinationEzetimibe 10mg · Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication · Combination
Kyung Dong Pharmaceutical Co., Ltd.
CombinationEzetimibe 10mg · Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.